Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Fifteen-Year Outcomes of the ProtecT Trial for Localized Prostate Cancer. Reply.

Journal article

Hamdy FC. and Donovan JL., (2023), N engl j med, 389

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.

Journal article

Hamdy FC. et al, (2023), N engl j med, 388, 1547 - 1558

Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment.

Journal article

Donovan JL. et al, (2023), Nejm evid, 2

Intermediate-risk Prostate Cancer-A Sheep in Wolf's Clothing?

Journal article

Heidegger I. et al, (2023), Eur urol oncol, 6, 103 - 109

Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial.

Journal article

Keeney E. et al, (2022), Pharmacoeconomics, 40, 1207 - 1220

Load More